Prostatic carcinoma--diagnosis, hormone therapy, radio- and chemotherapy
Ebert, T.; Bendhack, M.L.
Der Urologe. Ausg. a 36(6): 570-577
1997
ISSN/ISBN: 0340-2592 PMID: 9487598 Document Number: 477169
Document emailed within 1 workday
Related Documents
Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356Klosterhalfen, H. 1977: Hormone therapy of prostatic carcinoma Deutsche Medizinische Wochenschrift 102(25): 947
Studer, U.E. 1995: Advanced prostatic carcinoma--which hormone therapy when? Der Urologe. Ausg. a 34(5): 361-366
Bertelli, A. 1990: Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH Drugs under Experimental and Clinical Research 16(Suppl): 1-2
Vahlensieck, W.; Tümmers, H.; Tschischak, D. 1974: Diagnosis and therapy of prostatic carcinoma Fortschritte der Medizin 92(30): 1195-1198
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Gez, E.; Ben-Yosef, R.; Libson, E.; Biran, S. 1987: The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma Harefuah 112(5): 239-241
Hiraoka, Y.; Sa, I. 2002: Biochemical diagnosis of benign prostatic hyperplasia (including differential diagnosis with prostatic carcinoma) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 342-345
Stoter, G.; Jones, W.G. 1988: Chemotherapy of hormone refractory prostatic cancer Progress in Clinical and Biological Research 260: 123-125
Hellbardt, A.; Aapro, M.; Sappino, A.P.; Mirimanoff, R.O.; Mégevand, R. 1989: Neo-adjuvant radio-chemotherapy of epidermoid carcinoma of the esophagus Helvetica Chirurgica Acta 56(4): 435-441
Sack, H. 2002: Effectiveness of postoperative radio- and chemotherapy in N(+) esophageal carcinoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 178(2): 109-110
Asakawa, M. 1987: Present state and prospectives in the diagnosis and therapy of lung neoplasms. 6. Internal therapy--with special reference to chemotherapy of small cell carcinoma Hokkaido Journal of Medical Science 62(2): 216-219
Mottet, N.; Di Palma, M.; Costa, P. 2000: Simultaneous radio-chemotherapy for infiltrating bladder carcinoma. what is new since 1997? Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 10(4): 513-519
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Strelkov, R.B. 1967: Effect of neurolytic agents on the activity of sulfur containing radio protectors beta mercapto ethylamine radio protect cystamine radio protect beta aminoiso thiuronium bromide hydro bromide radio protect cysteine radio protect atropine radio protect hexonium radio protect methyl diazil radio protect dimedrol radio protect mouse Radiobiologiya 7(6): 939-940
Beckley, S.; Wajsman, Z.; Slack, N.; Mittelman, A.; Murphy, G.P. 1980: The chemotherapy of prostatic carcinoma Scandinavian Journal of Urology and Nephrology. Supplementum 55: 151-162
DeKernion, J.B.; Lindner, A. 1984: Chemotherapy of hormonally unresponsive prostatic carcinoma Urologic Clinics of North America 11(2): 319-326
Smith, P.H.; Akdas, A.; Mason, M.K.; Richards, B.; Robinson, M.R.; de Pauw, M.; Sylvester, R. 1980: Hormone therapy in prostatic cancer Acta Urologica Belgica 48(1): 98-105
Jackson, G.L.; Blosser, N.M. 1971: Surgical and radio-iodine therapy in thyroid carcinoma Pennsylvania Medicine 74(5): 77-83
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103